New biomarkers may achieve betterdisease phenotyping.12 Although,many reports have been published on HF biomarkers over the last decades, the impacton clinical decision making is still limited.13 BNP/NTproBNP demonstrated high clinical utility to identifypatients at high risk for heart failure hospitalization and death. The gene discussed is NPPB; the disease is hydrops fetalis.